
    
      The study objectives are to assess the efficacy and safety of the Selegiline Transdermal
      System (STS) in reducing cocaine use in subjects with cocaine dependence. It is hypothesized
      that selegiline treatment compared to placebo, will be associated with fewer days of cocaine
      use as assessed by self-report confirmed with urine assays for benzoylecgonine (BE).
    
  